XML 28 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
BUSINESS COMBINATIONS
6 Months Ended
Jun. 30, 2011
BUSINESS COMBINATIONS [Abstract]  
BUSINESS COMBINATIONS
NOTE 4 - BUSINESS COMBINATIONS

On February 18, 2011, Cosmed, a newly-formed subsidiary of Signature, acquired certain assets and assumed certain of the liabilities of Costru Company, LLC (“Costru”) for consideration totaling $2.7 million.  Cosmed, which does business under the trade name CosmedicineTM, manufactures a line of skin care products for women, which is available in retail stores across the country.  Signature currently owns 92% of the outstanding common stock of Cosmed, with the remaining 8% held by the former owners of Costru.

Under purchase accounting, the total purchase price was allocated to Costru's assets, identifiable intangible assets and liabilities based on their estimated fair values at the acquisition date. The estimated fair value of the noncontrolling interest was determined using a market value approach considering the fair values of the assets acquired and liabilities assumed, adjusted to account for the lack of control.

During the first quarter of 2011, the Company recorded acquisition-related costs of approximately $72 thousand, which are included in selling, general and administrative expenses in the Company's consolidated statement of operations for the six months ended June 30, 2011.

The following table presents the components of the purchase consideration and allocation of the purchase consideration to the estimated fair value of the assets acquired and liabilities assumed:

(Dollars in thousands)
   
Cash consideration
 $1,000 
Assumption of debt
  1,569 
Noncontrolling interest
  100 
Total purchase consideration
  2,669 
      
Purchase price allocation:
    
Trade receivables
  572 
Inventories
  1,350 
Property and equipment
  5 
Identifiable intangible assets
  1,225 
Trade payables
  (90)
Deferred tax liabilities
  (112)
Net assets acquired
  2,950 
      
Gain on acquisition
 $281 

The Company recorded a gain on acquisition of $0.3 million during the first quarter of 2011, based on the difference between the fair value of assets acquired and liabilities assumed and the total purchase consideration.  The gain recognized at the time of the acquisition resulted from depressed market conditions within the consumer products industry and Signature's ability to negotiate a purchase price below the estimated fair value of the net assets acquired.

In addition to the initial cash consideration, the Company is obligated to make an additional earn-out payment of up to $5.0 million, subject to a revenue target of $60.0 million in annualized revenues being achieved over any three month period within 36 months of the acquisition date, or if the Company sells Cosmed for at least $60.0 million during a specified time period, not to exceed 39 months from the acquisition date. At the acquisition date, management determined the fair value of this contingent consideration to be zero, based upon current and projected revenues over the requisite earn-out period.

The following table presents the estimated fair value of identifiable intangible assets and related estimated useful lives:

   
Estimated
  
Useful Life
 
(Dollars in thousands)
 
Fair Value
  
(Years)
 
Identifiable intangible assets:
      
Product formulas
 $800   10.0 
Trademarks
  190   10.0 
Customer lists
  125   3.0 
Domain names
  100   3.0 
Non-compete agreements
  10   10.0 
Identifiable intangible assets
 $1,225     

Total amortization of intangible assets was $78 thousand and zero for the three months ended June 30, 2011 and 2010, respectively.  Total amortization of intangible assets was $0.1 million and zero for the six months ended June 30, 2011 and 2010, respectively.

At June 30, 2011, aggregate future amortization of identifiable intangible assets is estimated to be:

(Dollars in thousands)
   
2011
 $155 
2012
  193 
2013
  164 
2014
  109 
2015
  101 
Thereafter
  399 
Total
 $1,121 

The operating results of Cosmed are included in the Company's consolidated financial statements since the acquisition date.  For the period from the acquisition date through June 30, 2011, Cosmed's total revenues and net loss were $0.8 million and $0.5 million, respectively.

The following unaudited pro forma results of operations of the Company for the three and six months ended June 30, 2011 and 2010, give effect to this business combination as though the transaction occurred on January 1, 2010:
 
   
Three Months Ended
  
Six Months Ended
 
   
June 30,
  
June 30,
 
(Dollars in thousands)
 
2011
  
2010
  
2011
  
2010
 
Revenues:
            
As reported
 $568  $80  $1,269  $175 
Pro forma
  568   1,236   1,817   1,673 
Net loss attributable to Signature Group Holdings, Inc.:
                
As reported
 $(6,155) $(11,621) $(10,368) $(21,977)
Pro forma
  (6,125)  (11,559)  (10,229)  (22,285)